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INTRODUCTION 
 
 Cancer is one of the most prevalent diseases in many countries worldwide. 
Cancer is a term describing conditions characterized by uncontrolled cellular proliferation 
and dedifferentiation. The exact cause of the disease remains enigmatic, but inhibition of 
the defence mechanism responsible for the elimination of disturbed cells is generally 
accepted as a background of carcinogenesis. 
 Apoptosis, or programmed cell death, is one of the most finely coordinated 
regulatory functions for maintenance of the homeostasis in the living organism. It involves 
the continuous checking of the cellular integrity and a cascade-like events of self-
destruction when the integrity of the organism is endangered. Morphological hallmarks of 
apoptosis are nuclear condensation, cell shrinkage, membrane blebbing and the formation 
of apoptotic bodies. These changes are accompanied by biochemical features, including 
DNA fragmentation and the proteolytic cleavage of a variety of intracellular substrates. 
Caspases are the best-characterized enzymes that perform this, while the Bcl-2 family is 
the principal set of proteins that regulate the apoptotic cascade. 
 The multidrug-resistance (MDR) of tumour cells to chemotherapeutic agents is a 
major problem in the clinical treatment of cancer. MDR is defined as the ability of 
malignant cells exposed to chemotherapeutics to develop resistance to a broad range of 
drugs due to the members of the ATP-binding cassette proteins. The best-examined 
member of the family is P-glycoprotein (Pgp), identified first in Chinese hamster ovary 
cells by Juliano and Ling in 1976. 
 The search for novel anticancer agents currently targets chemical entities that 
selectively induce apoptosis and/or reverse MDR. Approximately 60% of all drugs now 
undergoing clinical trials for the multiplicity of cancers are either natural products or 
compounds derived from natural sources. Plant extracts can be regarded as chemical 
libraries of structurally diverse compounds, their investigation therefore constituting a 
promising approach in drug discovery.  
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AIMS 
 
In accordance with the preceding approach, our aims were as follows: 
• To select plants, partly on the basis of literature surveys, for antiproliferative 
investigation. Hungarian species of the Asteraceae family were subjected to a 
systematic screening for cytostatic activity. 
• To identify pure compounds responsible for the detected cytotoxic activity of the 
extracts of Tamus communis L. 
• To investigate previously isolated, but not tested acridones from Ruta graveolens 
L. for anticancer activity. We focused on the elucidation of the mechanism of 
their apoptosis-inducing effects.  
• To explore acridones with the ability to inhibit Pgp-mediated MDR and to clarify 
their potential importance in a set of drug combination experiments.  
 
MATERIALS AND METHODS 
 
Plant material 
 The initial set of Asteraceae plants were collected in the flowering period from 
several regions of Hungary. Four crude extracts were prepared with n-hexane (extract A), 
chloroform (CHCl3) (extract B), and water (extract C). The residual plant material was 
extracted with boiling water, and freeze-dried (extract D).  
In the case of T. communis, the rhizomes were collected in the Mecsek Hills. The 
effective agent was determined by bioassay-guided fractionation, and finally identified. 
 The acridone alkaloids were provided as pure compounds (arborinine (1), 
evoxanthine (2), isogravacridone chlorine (3), rutacridone (4), gravacridonediol (5), 
gravacridonetriol (6), gravacridonediol monomethyl ether (7), gravacridonetriol 
monoglycoside (8) and gravacridonediol monoglycoside (9) (Fig. 1)). 
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Tumour cell lines 
Human (MCF7, HeLa and A431) and mouse (L5178 T-cell lymphoma, sensitive 
and Pgp-expressing variants) cancer cell lines were used. All these cell lines were cultured 
in the appropriate medium in a humidified atmosphere of 5% CO2 at 37 °C. 
 
MTT assay 
 Antiproliferative effects were measured in vitro by using MTT ([3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]) assays. After treatment, the living 
cells were assayed by the addition of 20 µl of 5 mg/ml MTT solution. Finally, the reduced 
MTT was assayed at 545 nm; wells with untreated cells were utilized as controls. 
Antiproliferative and cytotoxic effects were distinguished by cell number and the duration 
of treatment (72 h, 5000 cells/w, and 24 h, 25000 cells/w, respectively). Stock solutions of 
the tested materials were prepared with dimethyl sulfoxide (DMSO). The highest DMSO 
concentration (0.3%) of the medium did not have any significant effect on the cell 
proliferation. Extracts which demonstrated potent activity (growth inhibition > 50%) were 
selected for further in vitro testing (dose-response curve and cytotoxicity).  
To study the interactions between acridones and doxorubicin, a checkerboard 
method was applied. A series of 2-fold dilutions of the acridones was tested in combination 
with 2-fold dilutions of doxorubicin. The cell growth rate was determined with MTT 
staining; drug interactions were evaluated according to the following system (fractional 
inhibitory index = FIX): 
FIX < 0.5  Synergism      1 < FIX < 2 Indifferent effect 
FIX = 0.51-1 Additive effect     FIX > 2 Antagonism 
 
Transmembrane permeability assay 
 The transmembrane permeabilities were determined in parallel artificial 
membrane permeability assays (PAMPA) and log Pe values were calculated. n-Dodecane in 
n-hexane was used as lipid bilayer and the concentration of the tested acridone alkaloid in 
the acceptor plate was determined with a microplate reader at 340 nm after incubation for 
5 h. 
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Figure 1. Chemical structures of the acridone alkaloids. 
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Ethidium bromide and acridine orage dual staining  
 Staining with ethidium bromide (EB) and acridine orange (AO) was carried out 
after 24-h acridone treatment to visualize the basic morphological events of apoptosis. This 
staining allowed the identification of intact, early-apoptotic, late-apoptotic and necrotic 
cells. AO permeates all cells and makes the nuclei appear homogeneous green for live 
cells, and spotted green for early-apoptotic cells. EB is taken up by cells only when the 
cytoplasmic membrane integrity has been lost; it stains the nucleus red.  
 
Flow cytometric analysis 
For the measurement of cellular DNA content stained with propidium iodide, 
flow cytometric analysis was used after a 24-h treatment of HeLa cells. The percentages of 
the cells in the different cell-cycle phases (G1, S and G2/M) were calculated; the 
subdiploid fraction was regarded as the apoptotic cell population. 
1 2 3 
4 5 6 
7 8 9 
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The retention of rhodamine 123, an indicator of the total cellular efflux 
activity, was detected by flow cytometry as a functional index of Pgp activity. Verapamil 
was used as a positive control. The fluorescence activity ratio was calculated as the ratio of 
the fluorescence of the treated MDR and untreated cells. 
 
Reverse transcriptase-PCR studies 
 The effects of the tested compounds on the mRNA expression pattern of Bax, 
Bcl-2 and MDR1 were determined by RT-PCR technique. After treatment (24 h for HeLa, 
48 h for L5178 MDR cells), 106 cells were denaturated and cDNA was prepared in the 
presence of RT. Human and mouse glyceraldehyde-3-phosphate dehydrogenase primers 
were used as internal control. The sequences of the oligonucleotide primers for Bcl-2, Bax 
and MDR1 were the same as previously reported. 
 
RESULTS 
 
Asteraceae screening 
Species from the Asteraceae family were selected for screening of their 
antiproliferative effect, partly as a follow-up of ethnomedicinal uses, and partly randomly 
selected. 
From a set of 25 plant species of the four tribes [Astereae (6), Inuleae (3), 
Helianthae (5) and Anthemideae (11)], 228 different extracts were prepared from selected 
plant organs. These extracts were initially screened on three human cancer cell lines at 10 
µg/ml. This first selection resulted in 25 extracts that exerted ≥50% inhibition of 
proliferation on one or other cell line. For the selected extracts, IC50 values were 
determined; direct cytotoxic and cytostatic effects were distinguished at 30 µg/ml. 
Of the extracts, mainly fractions B (72% of the selected extracts), containing 
CHCl3-soluble lipophilic constituents, were found to be active. In some cases, the n-hexane 
and aqueous-MeOH extracts (fraction A and C, respectively) were also effective. None of 
the residual aqueous extracts (fraction D) demonstrated a pronounced antiproliferative 
effect (>50% inhibition) against any cell line. 
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For the active Anthemideae species, the extracts of the aerial parts proved to be 
effective. The extracts of A. collina exhibited some selectivity for dividing cells, as 
evidenced by the high cytostatic-cytotoxic differences. The extract from the roots of the 
Astereae plants seemed to be more effective than those from other organs, and the MCF7 
cells were slightly more sensitive than the other two cell lines. The n-hexane extracts of the 
roots of E. canadensis exhibited the highest activity in the tribe, and displayed substantial 
direct cytotoxic action. In the Heliantheae tribe, noteworthy antiproliferative activities were 
recorded for  A. artemisiifolia, H. annuus and X. italicum. The most potent extracts in the 
whole screen were the CHCl3 extracts of H. annuus and X. italicum, which had IC50 values 
<5 µg/ml on all cell lines. As concerns the Inuleae species, I. ensifolia was found to be 
moderately active, while T. speciosa proved to have marked efficacy. 
 
Bioassay-guided isolation of cytostatic compounds from the rhizome of T. communis 
The rhizome of T. communis was selected on an ethnomedicinal basis for 
bioassay-guided fractionation on HeLa cells, using the MTT assay. In the first set of 
experiments, the CHCl3 extract exhibited pronounced antiproliferative activity (IC50 0.02 
µg/ml), while the MeOH extract was inactive. For identification of components responsible 
for the effect of the extract, it was fractionated into 13 fractions. The fractions IV, V+VI, 
VIII, IX and XIII exhibited >50% activity at a concentration of 10 µg/ml. In further 
appropriate chromatographic steps, 5 active phenanthrenes were isolated from these active 
fractions. 
From fraction IV, 7-hydroxy-2,3,4-trimethoxyphenanthrene (10) and 2,7-
dihydroxy-3,4,8-trimethoxyphenanthrene (12) were isolated. 2,7-Dihydroxy-3,4-
dimethoxyphenanthrene (11) was purified from fractions V-VI, and 3,7-dihydroxy-2,4,8-
trimethoxyphenanthrene (13) and 3,7-dihydroxy-2,4-dimethoxyphenanthrene (14) from 
fractions VIII-IX (Table 1). Compound 10 is a new natural compound, while 11 (nudol), 
12 (confusarin) and 13 were first described in T. communis. Compound 14 (previously 
reported as TaVIII) was earlier isolated from the rhizomes of this plant. 
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Table 1. The structures and cytostatic activities of the phenanthrenes isolated from T. communis on 
HeLa cells. 
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Antitumour effects of the acridones 
 The antiproliferative effects and the lipid solubilities of the investigated 
compounds are listed in Table 2. Compound 1 proved to be an outstandingly potent 
cytostatic agent, especially against HeLa cells. The tested furacridones (3-9) exhibited 
slightly different sequences of cytostatic potency. The permeabilities of these compounds 
were characterized by PAMPA and log Pe values were calculated. The correlation 
coefficients between log Pe and IC50 were found to be 0.717, 0.856 and 0.578 for HeLa, 
MCF-7 and A431 cells, respectively.  
 
 
n.d.2.849.6312.43Cisplatin
n.d.0.150.280.15Doxorubicin
-6.359not active*not active*not active*8+9
-5.36111.9713.203.847
-5.86527.8899.6023.246
-5.08714.8319.917.875
-4.99414.417.695.274
-5.1083.024.538.353
n.d.not active*not active*not active*2
n.d.12.9511.741.841
A431MCF7HeLa
log Pe values
IC50 values (µM)
Compound
 
 
Table 2. IC50 and log Pe values of the tested compounds. * indicates that the compound did 
not inhibit cell proliferation to a significant level at 30 mM. 
n.d.: not determined 
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 The effect on the cell cycle profile was characterized by measuring the cellular 
DNA content. In the further tests, three selected acridones were studied for elucidation of 
their mechanism of action. The flow cytometry revealed that 3, 4 and 7 exerted effects on 
the cell cycle distribution. A 24-h exposure of HeLa cells resulted in an increased 
proportion of cells in the S phase, and a decreased proportion of cells in the G2/M phase. 
(Fig. 2). 
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Apoptosis induced by acridone alkaloids  
 The typical morphological features of apoptosis, including increased cell 
membrane permeability, cellular shrinkage and granulation in the nucleus, are major 
consequences of the apoptotic trigger. HeLa cells treated with 3, 4 or 7 exhibited apoptotic 
morphological changes, as detected with AO/EB double staining. 
The degradation of nuclear DNA was detected by flow cytometry While the 
subG1 position of the vehicle-treated cells was <5%, 3, 4 and 7-treated cells cantained a 
lower amount of DNA, which increased concentration-dependently (Fig. 3).  
 To further characterize acridone-induced apoptosis, apoptosis-promoting (Bax) 
and apoptosis-preventing (Bcl-2) proteins were measured at the mRNA level. A 
concentration-dependent decrease in Bcl-2 mRNA expression was observed in HeLa cells 
treated with acridone alkaloids for 24 h. On the other hand, only a tendency to an increase 
was observed at the Bax mRNA level. The increase in Bax/Bcl-2 may explain the apoptotic 
Figure 2. Cell cycle analysis: 
effects of acridones on HeLa 
cells after 24-h treatment. * and 
** denote p < 0.05 and p < 
0.01, respectively, as compared 
with the control value. 
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effects of 3 and 4 (Fig. 4), which is partly mediated via a Bax/Bcl-2-regulated 
mitochondrial pathway 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Inhibition of MDR by acridone alkaloids 
To evaluate the ability to inhibit the Pgp-mediated drug efflux, acridone alkaloids 
were tested in the rhodamine 123 accumulation assay on the L5178 MDR mouse 
lymphoma cell line. 40 µM of compound 3, 4, 5 or 6 inhibited the pump function of Pgp 
more efficiently than the positive control verapamil at 40.6 µM. Of these compounds, 5 
proved to have the most marked MDR reversal effect (Table 3). 
 
 
Figure 3. DNA 
fragmentation assay. 
subG1 population of 
HeLa cells after 24-h 
treatment with acridones. 
* and ** denote p < 0.05 
and p < 0.01,  
respectively, as compared 
with the control. 
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Rutacridone Isogravacridone chlorine 
Figure 4. Effects of rutacridone and isogravacridone chlorine on Bax/Bcl-2 mRNA expression of 
HeLa cells after a 24-h treatment *, ** and *** denote p < 0.05, p < 0.01 and  
p < 0.001, respectively, as compared with the control value. 
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DISCUSSION 
 
 In this work, naturally occurring compounds with cytostatic activity towards 
tumour cells were sought, detected and evaluated. Screening of four extracts of plants of 
the Asteraceae family for antiproliferative activity resulted in promising starting sources 
for further investigation. The measured activities were compared with the ethnomedicinal 
uses of the plants with potent antiproliferative activity and it was concluded that the present 
screening results for E. canadensis, E. annuus, A. artemisiifolia, H. annuus and X. italicum 
are in accord with the traditional use of the plants against tumours. A survey of the 
literature data revealed that the antitumour activities of E. canadensis, I. ensifolia and A. 
ruthenica had not been reported earlier. Extracts which exhibited substantial 
antiproliferative activity may represent a source for novel natural anticancer entities. 
 The bioassay-guided fractionation of the CHCl3 fraction of the rhizomes from T.  
communis led to the identification of five phenanthrenes. The cytotoxic assay of the 
isolated molecules revealed that compounds 10-12 and 14 exerted marked cell growth-
inhibitory activity on the HeLa cell line. Compound 10 is a new natural product, while 11-
13 had been previously described in other species.  
 The effects of acridone alkaloids on cell proliferation and apoptosis may involve 
different mechanisms. Compound 3 and 7 increased the S phase, while G2/M was 
decreased, suggesting a perturbation of the cell cycle, blocking the transition from the S to 
Table 3. Effect of 
acridones on the Rh-
123 accumulation 
assay in L5178 
MDR cells. 
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the G2 phase. Cellular shrinkage, nuclear condensation and increased membrane 
permeability (typical morphological apoptotic markers) were observed after the 24-h 
treatment. The subdiploid DNA population and the increased Bax/Bcl-2 mRNA confirmed 
the apoptosis-inducing activity of acridones. 
 Furanoacridones proved to be effective in reversing Pgp-mediated MDR in the 
rhodamine 123 accumulation assay. This effect was reinforced by a potentiation of the 
cytostatic effect of doxorubicin by some of the acridones. Compounds 6 and 7 not only 
blocked the function of Pgp, but also decreased the mRNA expression of MDR1. 
 In summary, our results indicate that naturally occurring plant components, 
including acridone alkaloids and phenanthrenes, may be used as starting structures for the 
potential development of novel anticancer agents. 
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